NASDAQ: HUMAHumacyte Inc Stock Ownership - Who owns Humacyte?
Insider buying vs selling
Have Humacyte Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brady W. Dougan | Director | 2025-08-20 | 591,685 | $1.58 | $934.86kSell |
| Laura E. Niklason | President CEO and Director | 2025-08-20 | 591,685 | $1.58 | $934.86kSell |
| Brady W. Dougan | Director | 2025-08-19 | 1,100,000 | $1.63 | $1.79MSell |
| Laura E. Niklason | President CEO and Director | 2025-08-19 | 1,100,000 | $1.63 | $1.79MSell |
| Brady W. Dougan | Director | 2025-08-18 | 549,360 | $1.83 | $1.01MSell |
| Laura E. Niklason | President CEO and Director | 2025-08-18 | 549,360 | $1.83 | $1.01MSell |
| William John Scheessele | Chief Commercial Officer | 2025-04-14 | 6,493 | $1.54 | $10.00kBuy |
| Shamik J. Parikh | Chief Medical Officer | 2025-04-10 | 7,500 | $1.55 | $11.63kBuy |
| Dale A. Sander | CFO and Chief Corp. Deve. Off. | 2025-04-10 | 20,000 | $1.53 | $30.60kBuy |
| Kathleen Sebelius | Director | 2025-04-08 | 50,000 | $1.32 | $66.00kBuy |
HUMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HUMA insiders and whales buy or sell their stock.
HUMA Shareholders
What type of owners hold Humacyte Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fresenius Medical Care Holdings Inc | 9.78% | 18,312,735 | $18.50M | Insider |
| Blackrock Inc | 6.06% | 11,345,119 | $11.46M | Institution |
| Vanguard Group Inc | 4.49% | 8,416,971 | $8.50M | Institution |
| Ayabudge LLC | 4.37% | 8,191,140 | $8.27M | Insider |
| Geode Capital Management LLC | 1.99% | 3,720,436 | $3.76M | Institution |
| Ubs Group Ag | 1.59% | 2,978,610 | $3.01M | Institution |
| State Street Corp | 1.52% | 2,837,276 | $2.87M | Institution |
| Morgan Stanley | 1.34% | 2,505,428 | $2.53M | Institution |
| Brady W. Dougan | 0.74% | 1,392,091 | $1.41M | Insider |
| Laura E. Niklason | 0.74% | 1,392,091 | $1.41M | Insider |
HUMA vs Biotech Stocks
Humacyte Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.